These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11742895)

  • 21. Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation.
    Wan Yau Ming S; Haughney J; Small I; Wolfe S; Hamill J; Gruffydd-Jones K; Daly C; Soriano JB; Gardener E; Skinner D; Stagno d'Alcontres M; Price DB
    Respir Med; 2017 Aug; 129():199-206. PubMed ID: 28732831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K; Borker R; Emmett A; Rickard K; Dorinsky P
    Pharmacoeconomics; 2002; 20(13):909-18. PubMed ID: 12381242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-inhaler combination therapy for asthma: a review of cost effectiveness.
    Akazawa M; Stempel DA
    Pharmacoeconomics; 2006; 24(10):971-88. PubMed ID: 17002480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children.
    Barnes NC; Thwaites RM; Price MJ
    Respir Med; 1999 Jun; 93(6):402-7. PubMed ID: 10464822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Call for withdrawal of LABA single-therapy inhaler in asthma.
    Beasley R; Perrin K; Weatherall M; Wijesinghe M
    Lancet; 2010 Sep; 376(9743):750-1. PubMed ID: 20816529
    [No Abstract]   [Full Text] [Related]  

  • 26. Asthma: the role of fluticasone propionate.
    Br J Hosp Med; 1997 Dec; 58(11):555-64. PubMed ID: 10193470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children].
    Rely K; McQuire SE; Alexandre PK; Escudero GS
    Value Health; 2011; 14(5 Suppl 1):S43-7. PubMed ID: 21839898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of prevalence, cost, and outcomes of a combination of salmeterol and fluticasone therapy to common asthma treatments.
    Wang SW; Liu X; Wiener DJ; Sennett C; Bowers BW; Legorreta AP
    Am J Manag Care; 2001 Sep; 7(9):913-22. PubMed ID: 11570024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves.
    Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):181-9. PubMed ID: 16136769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
    Aballéa S; Cure S; Vogelmeier C; Wirén A
    Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
    Meltzer EO; Lockey RF; Friedman BF; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
    Mayo Clin Proc; 2002 May; 77(5):437-45. PubMed ID: 12004993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma.
    Rodríguez-Martínez CE; Sossa-Briceño MP; Castro-Rodriguez JA
    J Asthma; 2013 May; 50(4):410-8. PubMed ID: 23356720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
    Kupryś-Lipińska I; Tworek D; Vanderbist F; Bocheńska-Marciniak M; Kuna P
    Pneumonol Alergol Pol; 2013; 81(6):527-36. PubMed ID: 24142782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.
    Braunstein G; Sharma R
    Respir Med; 2000 Jun; 94 Suppl B():S1-2. PubMed ID: 10919678
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma.
    Markham A; Adkins JC
    Pharmacoeconomics; 2000 Dec; 18(6):591-608. PubMed ID: 11227397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
    Allen-Ramey FC; Anstatt DT; Sajjan SG; Markson LE
    Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Budget impact analysis of a fixed-dose combination of fluticasone propionate and formoterol fumarate (FP/FORM) in a pressurized metered-dose inhaler (pMDI) for asthma.
    Dunlop W; Heron L; Fox G; Greaney M
    Adv Ther; 2013 Oct; 30(10):933-44. PubMed ID: 24194361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.
    Nathan RA; Li JT; Finn A; Jones R; Payne JE; Wolford JP; Harding SM
    Chest; 2000 Aug; 118(2):296-302. PubMed ID: 10936116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ease of handling and clinical efficacy of fluticasone propionate Accuhaler/Diskus inhaler compared with the Turbohaler inhaler in paediatric patients. UK Study Group.
    Williams J; Richards KA
    Br J Clin Pract; 1997; 51(3):147-53. PubMed ID: 9293055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.